ArticleCancers2023

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

François Cousin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.